IDXX — IDEXX Laboratories Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareBalancedLarge CapHigh Flyer

Annual balance sheet for IDEXX Laboratories, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	384	144	113	454	288
Net Total Accounts Receivable
Net Total Receivables	375	426	491	530	561
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	1,063	956	1,101	1,495	1,400
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	646	693	768	818	829
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	2,295	2,437	2,747	3,260	3,293
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	583	764	1,236	952	1,068
Long Term Debt
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Liabilities	1,662	1,747	2,138	1,775	1,698
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Unrealized Gain / Loss
Other Equity
Total Equity	632	690	609	1,485	1,595
Total Liabilities & Shareholders' Equity	2,295	2,437	2,747	3,260	3,293
Total Common Shares Outstanding